Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LP-118 |
Trade Name | |
Synonyms | LP 118|LP118 |
Drug Descriptions |
LP-118 inhibits BCL2 and BCL-XL, potentially leading to apoptosis of tumor cells and reduced tumor growth (Blood (2021) 138 (Supplement 1): 679). |
DrugClasses | BCL-XL inhibitor 14 BCL2 inhibitor 27 |
CAS Registry Number | NA |
NCIT ID | C185878 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LP-118 | LP-118 | 0 | 1 |
LP-118 + Ponatinib | LP-118 Ponatinib | 0 | 1 |